Bariatric surgery: Shedding the monetary weight of prescription costs in the managed care arena

Obesity Surgery

Volumn 14, Issue 6, 2004, Pages 725-730

  Potteiger, Chad E ^a   Paragi, Prakash R ^a   Inverso, Nicholas A ^a   Still, Christopher ^a   Reed, Mary Jane ^a   Strodel III, William ^a   Rogers, Marc ^a   Petrick, Anthony ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

Bariatric surgery; Costs; Diabetes; Gastric bypass; Hypertension; Medications; Morbid obesity

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ANALYTIC METHOD; BARIATRIC SURGERY; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; COST CONTROL; DATA BASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG COST; DRUG UTILIZATION; ELECTRONICS; FEMALE; HEALTH CARE COST; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MONEY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; ROUX Y ANASTOMOSIS; SURGICAL PATIENT;

ADULT; ANTIHYPERTENSIVE AGENTS; COST SAVINGS; DIABETES MELLITUS; DRUG COSTS; FEMALE; GASTRIC BYPASS; HUMANS; HYPERTENSION; LAPAROSCOPY; MALE; MIDDLE AGED; MORBIDITY; OBESITY; OBESITY, MORBID; PENNSYLVANIA; RETROSPECTIVE STUDIES;

EID: 3242810485     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/0960892041590999     Document Type: Review

References (30)

1. Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-9.
2. Levit K, Smith C, Cowan C et al. Inflation spurs health spending in 2000. Health Aff (Millwood). 2002 Jan-Feb; 21(1): 172-81.
3. Strunk BC, Ginsburg PB, Gabel JR. Tracking health care costs: growth accelerates again in 2001. Health Affairs (Millwood). 2002; Supp Web Exclusives: W299-310.
4. Kaiser Family Foundation. Prescription drug trends - A chartbook (Nov 2001).
5. Prescription drug expenditures in 2001: Another year of Escalating Costs. A report by The National Institute for Health Care Management Research and Educational Foundation. 2002 May; 1-19.
6. Heffler S, Smith S, Won G et al. Health spending projections for 2001-2011: the latest outlook. Health Affairs (Millwood). 2002 Mar-Apr; 21(2): 207-18.
7. Strum R. the effects of obesity, smoking, and drinking on medical problems and costs. Health affairs; 21: 245-53.
8. Finkelstein EA, Fiebelkorn, Wang G. National medical spending attributable to overweight and obesity: How much, and who's paying? Health Affairs 2003; 3: 219-26.
9. Pi-Sunyer FX. The medical risks of obesity. Obes Surg 2002; 12 (Suppl 1): 6S-11S.
10. Troiano RP, Frongillo EA, Sobal J et al. The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies. Int J Obes 1996; 20: 63-75.
11. Manson JE, Willet WC, Stampfer MJ et al. Bodyweight and mortality among women. N Engl J Med 1995; 333: 677-85.
12. Stevens J, Cai J, Pamuk ER et al. The effect of age on the association between body-mass index and mortality. N Engl J Med 1998; 3381-7.
13. Calle EE, Thun MJ, Petrelli JM et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-1105.
14. Sjostrom CD, Lissner L, Wedel H et al. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999; 7: 477-84.
15. Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res 1998; 6: 97-106.
16. Quesenberry CP, Caan B, Jacobson A. Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med 1998; 158: 466-72.
17. Hodgson TA, Cai L. Medical care expenditures for hypertension, its complications, and its comorbidites. Med Care 2001; 39: 599-615.
18. Fontaine KR, Faith MS, Allison DB et al. Body weight and health care among women in the general population. Arch Fam Med 1998; 7: 381-4.
19. Collins WR, Anderson JW. Medication cost savings associated with weight loss for obese non-insulin dependent diabetic men and women. Prev Med 1995; 24: 369-74.
20. Thompson D, Edelsberg J, Colditz GA et al. Lifetime health and economic consequences of obesity. Arch Intern Med 1999; 159: 2177-83.
21. Heithoff KA, Cuffel BJ, Kennedy S et al. Th association between body mass and health care expenditures. Clin Ther 1997; 19: 811-20.
22. Red Book 2003 Drug Topics: The Pharmacist's Trusted Companion for More Than a Century. Medical Economics Staff, Harold E. Cohen. Montvale, NJ: Medical Economics, June 2003.
23. Greenway FL, Ryan DH, Smith SR et al. Pharmaceutical cost savings of treating obesity with weight loss medications. Obes Res. 1999; 7: 523-31.
24. Craig BM, Tseng DS. Cost-effectiveness of gastric bypass for severe obesity. Am J Med 2002; 113: 491-8.
25. Monk JS, Dia Nagib N, Stehr W. Pharmaceutical savings after gastric bypass surgery. Obes Surg 2003, 14; 13-5.
26. Gallagher SF, Banasiak M, Gonzalvo JP et al. The impact of bariatric surgery on the Veterans Administration Healthcare System: a cost analysis. Obes Surg 2003; 13: 245-8.
27. Clegl A. Colquitt J, Sidhe M et al. Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes 27; 1167-77.
28. Martin LF, Tan TL, Hunter SM et al. Comparison of the costs associated with medical and surgical treatment of obesity. Surgery 1995; 118: 599-606; Discussion 606-7.
29. Rasheid S, Banasiak M, Gallagher SF et al. Gastric bypass is an effective treatment for obstructive sleep apnea in patients with clinically significant obesity. Obes Surg 2003; 13: 58-61.
30. Smith S, Edwards C, Goodman G. Systematic and clinical improvement in morbidly obese patients with gastroesophageal reflux disease following Roux-en-Y gastric bypass. Obes Surg 1997; 7: 479-84.